Nothing Special   »   [go: up one dir, main page]

FR2368959A1 - Compositions contenant des derives de l'acide guanidinoalcanoique, utilisables comme medicament - Google Patents

Compositions contenant des derives de l'acide guanidinoalcanoique, utilisables comme medicament

Info

Publication number
FR2368959A1
FR2368959A1 FR7732620A FR7732620A FR2368959A1 FR 2368959 A1 FR2368959 A1 FR 2368959A1 FR 7732620 A FR7732620 A FR 7732620A FR 7732620 A FR7732620 A FR 7732620A FR 2368959 A1 FR2368959 A1 FR 2368959A1
Authority
FR
France
Prior art keywords
guanidinoalcanoic
compositions containing
acid derivatives
medicinal product
composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
FR7732620A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Beecham Group PLC
Original Assignee
Beecham Group PLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Beecham Group PLC filed Critical Beecham Group PLC
Publication of FR2368959A1 publication Critical patent/FR2368959A1/fr
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Diabetes (AREA)
  • Emergency Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Engineering & Computer Science (AREA)
  • Endocrinology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Cette invention concerne une composition ayant une activité biologique. Cette composition renferme un mélange d'un dérivé d'acide guanidino-alcanoïque et un inhibiteur de gluconéogenèse hépatique. Elle est utilisable pour le traitement d'affections hyperglycémiques comme le diabète sucré.
FR7732620A 1976-11-02 1977-10-28 Compositions contenant des derives de l'acide guanidinoalcanoique, utilisables comme medicament Withdrawn FR2368959A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB45450/76A GB1552179A (en) 1976-11-02 1976-11-02 Pharmaceutical compositions for treating hyperglycaemia

Publications (1)

Publication Number Publication Date
FR2368959A1 true FR2368959A1 (fr) 1978-05-26

Family

ID=10437252

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7732620A Withdrawn FR2368959A1 (fr) 1976-11-02 1977-10-28 Compositions contenant des derives de l'acide guanidinoalcanoique, utilisables comme medicament

Country Status (12)

Country Link
JP (1) JPS5362834A (fr)
AU (1) AU2998777A (fr)
BE (1) BE860307A (fr)
DE (1) DE2747764A1 (fr)
DK (1) DK485777A (fr)
FI (1) FI773213A (fr)
FR (1) FR2368959A1 (fr)
GB (1) GB1552179A (fr)
IL (1) IL53207A0 (fr)
NL (1) NL7711993A (fr)
SE (1) SE7712328L (fr)
ZA (1) ZA776432B (fr)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0370994A2 (fr) * 1988-11-25 1990-05-30 Gert Prof. Dr. Lubec Traitement de liaisons transversales du collagène, initiées par le glucose chez les diabétiques, par l'arginine, la spermidine, la créatine ou l'agmatine

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1991012799A1 (fr) * 1990-02-28 1991-09-05 The Upjohn Company Utilisation d'acide 3-guanidinopropionique dans le traitement et la prevention de troubles du metabolisme
US5599841A (en) * 1990-02-28 1997-02-04 The Upjohn Company Use of 3-guanidinopropionic acid in the treatment and prevention of metabolic disorders
US6008253A (en) * 1991-08-26 1999-12-28 The Upjohn Company Use of 3-guanidinopropionic acid to increase endurance, stamina and exercise capacity in a mammal
JPH06510286A (ja) * 1991-08-26 1994-11-17 ファルマシア・アンド・アップジョン・カンパニー ３−グアニジノプロピオン酸およびピオグリタゾン、グリベンクラミドまたはグリメピリドを含有する医薬組成物
ATE158589T1 (de) * 1991-11-22 1997-10-15 Yeda Res & Dev Nicht-peptidische surrogate der arg-gly-asp sequenz und entsprechende pharmazeutische zusammensetzungen
AU721190B2 (en) * 1995-10-11 2000-06-29 Avicena Group, Inc. Use of creatine analogues for the treatment of disorders of glucose metabolism
US6099859A (en) 1998-03-20 2000-08-08 Andrx Pharmaceuticals, Inc. Controlled release oral tablet having a unitary core
AU2005265164A1 (en) * 2004-06-17 2006-01-26 Musc Foundation For Research Development Non-natural amino acids
DE102007034102A1 (de) * 2007-07-21 2009-01-22 Alzchem Trostberg Gmbh Abriebfeste und rieselfähige Glycocyamin-haltige Formlinge und Verfahren zu deren Herstellung

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1195199A (en) * 1966-11-25 1970-06-17 Horlicks Pharmaceuticals Ltd Improvements in Compositions comprising Insulin.

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1195199A (en) * 1966-11-25 1970-06-17 Horlicks Pharmaceuticals Ltd Improvements in Compositions comprising Insulin.

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0370994A2 (fr) * 1988-11-25 1990-05-30 Gert Prof. Dr. Lubec Traitement de liaisons transversales du collagène, initiées par le glucose chez les diabétiques, par l'arginine, la spermidine, la créatine ou l'agmatine
EP0370994A3 (en) * 1988-11-25 1990-12-27 Gert Prof. Dr. Lubec Treatment of glucose-intermediated cross-linking of collagen in patients with diabetes mellitus by arginin, spermidin, creatin or agmatin

Also Published As

Publication number Publication date
NL7711993A (nl) 1978-05-05
FI773213A (fi) 1978-05-03
SE7712328L (sv) 1978-05-02
AU2998777A (en) 1979-05-03
DK485777A (da) 1978-05-03
IL53207A0 (en) 1977-12-30
ZA776432B (en) 1978-08-30
BE860307A (fr) 1978-04-28
GB1552179A (en) 1979-09-12
DE2747764A1 (de) 1978-05-03
JPS5362834A (en) 1978-06-05

Similar Documents

Publication Publication Date Title
FR2455028A1 (fr) Nouveaux amides d'acylcarnitines, utiles notamment comme stimulants du systeme nerveux central, et leur procede de preparation
FR2453148A1 (fr) Nouveaux derives arylsulfinyle d'acide acetohydroxamique, leur procede de preparation et leur application en therapeutique
FR2430410A1 (fr) Phenethanolamines et compositions pharmaceutiques en contenant
FR2427329A1 (fr) Nouveaux derives d'acides phenoxyalkylcarboxyliques et leur application en therapeutique, notamment en tant qu'agents hypolipidemiants et hypocholesterolemiants
FR2392667A1 (fr) Composition pharmaceutique a liberation etalee comprenant du propranolol
FR2415112A1 (fr) Nouveaux derives spirothienohydantoines et composition pharmaceutique les contenant
ATE60579T1 (de) Pyrrolidinamid-derivate mit antipropylendopeptidase-wirkung, zusammenstellungen, die sie enthalten, verfahren zu ihrer herstellung und heilmittel, die sie enthalten.
BE903183A (fr) Nouveaux derives du benzonorbornene, leurs procedes de preparation et composition medicamenteuse et cosmetique les contenant
FR2368959A1 (fr) Compositions contenant des derives de l'acide guanidinoalcanoique, utilisables comme medicament
FR2397403A1 (fr) Nouveaux derives de 1-acyl 2-cyano-aziridine, procede pour leur preparation et compositions pharmaceutiques contenant ces composes
JPS5665869A (en) Novel 22hydroxyalkyll3*4*55trihydroxyypiperidine compound* its manufacture and drug
FR2393577A1 (fr) Medicament a base d'acide b-(p-halogenophenyl)-g-aminobutyrique destine au traitement de la nevrose d'angoisse
FR2457689A1 (fr) Medicament hypolipemique a base de carnitine
FR2358415A1 (fr) Derives peptidiques, leur preparation et leur application en tant que medicaments
FR2453152A1 (fr) Nouveaux derives de prostaglandine et medicament les contenant
FR2414042A1 (fr) Procede de production de n-methylmoranoline et nouveau produit ainsi obtenu
FR2428436A1 (fr) Nouvelles compositions cosmetiques pour le traitement de l'etat gras des cheveux et de la peau, composes nouveaux et leur procede de preparation
ATE110568T1 (de) Pharmazeutisches präparat zur behandlung des katarakts.
FR2450837A1 (fr) Acides penicillaniques 6-b-substitues inhibiteurs de b-lactamase, leur procede de production et composition pharmaceutique les contenant
FR2401141A1 (fr) Nouveaux derives halogenes de prostaglandines et medicaments les contenant
FR2440353A1 (fr) Nouveaux arylethanols, leurs procedes d'obtention et leur emploi comme medicament
FR2369216A1 (fr) Produits pour le traitement d'eaux, contenant des acides acylimino diacetiques
FR2380778A1 (fr) Compositions pharmaceutiques contenant des acides oxaniliques substitues ou leurs esters
ES466239A1 (es) Un procedimiento de preparacion de azacicloalcanos, azaci- cloalquenos y sus derivados
FR2383176A1 (fr) Amino aryl triazines 1-2-4 utilisables dans le traitement d'algies diverses

Legal Events

Date Code Title Description
ST Notification of lapse